FINAL RESULTS FROM THE PHASE 3 REGENERATE TRIAL EVALUATING THE EFFECTS OF OBETICHOLIC ACID IN PATIENTS WITH PRE-CIRRHOTIC FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS

被引：0
|
作者：
Sanyal, Arun J.
Loomba, Rohit
Anstee, Quentin M.
Ratziu, Vlad
Kowdley, Kris V.
Lawitz, Eric
Berrey, M. Michelle
White, Christopher
Sawhney, Sangeeta
Capozza, Thomas
Leyva, Rina
Younossi, Zobair M.
Rinella, Mary
Abdelmalek, Manal F.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1057e
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Final results from the phase 3 REGENERATE trial evaluating the effects of obeticholic acid in patients with pre-cirrhotic fibrosis due to metabolic dysfunction-associated steatohepatitis
    Sanyal, Arun J.
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Kowdley, Kris V.
    Lawitz, Eric
    White, Christopher
    Sawhney, Sangeeta
    Capozza, Thomas
    Leyva, Rina
    Younossi, Zobair
    Rinella, Mary E.
    Abdelmalek, Manal F.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S95 - S95
  • [2] Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
    Sanyal, Arun J.
    Ratziu, Vlad
    Loomba, Rohit
    Anstee, Quentin M.
    Kowdley, Kris, V
    Rinella, Mary E.
    Sheikh, Muhammad Y.
    Trotter, James F.
    Knapple, Whitfield
    Lawitz, Eric J.
    Abdelmalek, Manal F.
    Newsome, Philip N.
    Boursier, Jerome
    Mathurin, Philippe
    Dufour, Jean-Francois
    Berrey, M. Michelle
    Shiff, Steven J.
    Sawhney, Sangeeta
    Capozza, Thomas
    Leyva, Rina
    Harrison, Stephen A.
    Younossi, Zobair M.
    JOURNAL OF HEPATOLOGY, 2023, 79 (05) : 1110 - 1120
  • [3] EFFECT OF CONCOMITANT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FROM THE REGENERATE TRIAL OF OBETICHOLIC ACID FOR THE TREATMENT OF PRE-CIRRHOTIC FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS
    Kowdley, Kris V.
    Randhawa, Amarita
    Li, Jing
    Patel, Hiral
    Gasink, Christopher
    Sawhney, Sangeeta
    Isaacs, Scott
    HEPATOLOGY, 2023, 78 : S1196 - S1198
  • [4] REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
    Ratziu, Vlad
    Sanyal, Arun J.
    Loomba, Rohit
    Rinella, Mary
    Harrison, Stephen
    Anstee, Quentin M.
    Goodman, Zachary
    Bedossa, Pierre
    MacConell, Leigh
    Shringarpure, Reshma
    Shah, Amrik
    Younossi, Zobair
    CONTEMPORARY CLINICAL TRIALS, 2019, 84
  • [5] TOPLINE RESULTS FROM A NEW ANALYSIS OF THE REGENERATE TRIAL OF OBETICHOLIC ACID FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
    Sanyal, Arun J.
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Kowdley, Kris V.
    Rinella, Mary E.
    Sheikh, Muhammad Y.
    Trotter, James F.
    Knapple, Whitfield L.
    Lawitz, Eric J.
    Abdelmalek, Manal F.
    Newsome, Philip N.
    Hansen, Bettina E.
    Mathurin, Philippe
    Dufour, Jean-Francois
    Berrey, M. Michelle
    Shiff, Steven J.
    Sawhney, Sangeeta
    Capozza, Thomas
    Leyva, Rina
    Harrison, Stephen A.
    Younossi, Zobair M.
    HEPATOLOGY, 2023, 77 (05) : E123 - E124
  • [6] OBETICHOLIC ACID IMPROVES EXPERIMENTAL NONINVASIVE MARKERS OF NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS: RESULTS FROM REGENERATE
    Boursier, Jerome
    Loomba, Rohit
    Anstee, Quentin
    Harrison, Stephen
    Sanyal, Arun
    Rinella, Mary
    Younossi, Zobair
    Goodman, Zachary
    Bedossa, Pierre
    Fournier, Celine
    Stenkilsson, Michael
    Shringarpure, Reshma
    Zaru, Luna
    Venugopal, Aditya
    MacConnell, Leigh
    Ratziu, Vlad
    Al-Shamma, Safa
    GUT, 2021, 70 : A14 - A15
  • [7] TOPLINE RESULTS FROM THE REVERSE TRIAL OF OBETICHOLIC ACID IN PATIENTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS
    Ratziu, Vlad
    Sanyal, Arun
    Kowdley, Kris V.
    Loomba, Rohit
    Harrison, Stephen A.
    Anstee, Quentin M.
    Younossi, Zobair M.
    Shiffman, Mitchell L.
    Lawitz, Eric
    Sawhney, Sangeeta
    Capozza, Thomas
    Abdelmalek, Manal F.
    Rinella, Mary
    HEPATOLOGY, 2023, 78 : S1225 - S1230
  • [8] NEW SAFETY AND EFFICACY ANALYSES FROM THE REGENERATE TRIAL OF OBETICHOLIC ACID FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
    Rinella, Mary
    Sanyal, Arun J.
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Kowdley, Kris V.
    Lawitz, Eric
    Abdelmalek, Manal F.
    Berrey, M. Michelle
    White, Christopher
    Shiff, Steven J.
    Sawhney, Sangeeta
    Capozza, Thomas
    Leyva, Rina
    Harrison, Stephen A.
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2023, 164 (06) : S1250 - S1251
  • [9] OBETICHOLIC ACID TREATMENT IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: A SECONDARY ANALYSIS OF THE REGENERATE STUDY ACROSS FIBROSIS STAGES
    Sanyal, Arun J.
    Ratziu, Vlad
    Loomba, Rohit
    Rinella, Mary E.
    Anstee, Quentin M.
    Goodman, Zachary D.
    Bedossa, Pierre
    Khalili, Mandana
    Boursier, Jerome
    Stinton, Laura
    Marchesini, Giulo
    Allison, Michael E.
    George, Jacob
    Arkkila, Perttu
    Zaru, Luna
    MacConell, Leigh
    Shringarpure, Reshma
    Younossi, Zobair M.
    HEPATOLOGY, 2019, 70 : 23A - 24A
  • [10] OBETICHOLIC ACID TREATMENT OF FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS REDUCES INCIDENCE OF DIARRHEA BUT INCREASES CONSTIPATION: AN ANALYSIS BASED ON ADVERSE EVENTS FROM THE REGENERATE TRIAL
    Walters, Julian R.
    Erickson, Mary
    Capozza, Thomas
    White, Christopher
    Shiff, Steven J.
    GASTROENTEROLOGY, 2023, 164 (06) : S1310 - S1310
12345